Urinary catheter treatment

Patent metadata

Field	Value
Publication number	US-12478767-B2
Application number	US-202117916491-A
Country	US
Kind code	B2
Filing date	Mar 31, 2021
Priority date	Apr 2, 2020
Publication date	Nov 25, 2025
Grant date	Nov 25, 2025

Abstract

A method includes mixing a liquid carrier and a powder formulation including an S-nitrosothiol (RSNO) powder to form a nitric oxide generating solution; and within a predetermined time of mixing, introducing the nitric oxide generating solution into an inflatable and nitric oxide permeable balloon of a urinary catheter that is inserted in a patient.

First claim

What is claimed is:

1 . A method, comprising:
mixing a liquid carrier and a powder formulation including an S-nitrosothiol (RSNO) powder to form a nitric oxide generating solution; within a predetermined time of mixing, introducing the nitric oxide generating solution into an inflatable and nitric oxide permeable balloon of a urinary catheter that is inserted in a patient; draining the nitric oxide generating solution from the inflatable and nitric oxide permeable balloon; mixing a second liquid carrier and a second powder formulation including an S-nitrosothiol (RSNO) powder to form a second nitric oxide generating solution; and within a predetermined time of the draining and the mixing, introducing the second nitric oxide generating solution into the inflatable and nitric oxide permeable balloon of the urinary catheter that remains inserted in the patient.

2 . The method as defined in claim 1 , further comprising adjusting a pH of the nitric oxide generating solution to a value ranging from 5 to 8 prior to introducing the nitric oxide generating solution into the inflatable and nitric oxide permeable balloon.

3 . The method as defined in claim 1 , further comprising allowing the urinary catheter, with the solution in the inflatable and nitric oxide permeable balloon, to remain in the patient for a duration ranging from 1 day to up to seven days after the nitric oxide generating solution is introduced.

4 . The method as defined in claim 1 wherein the mixing involves adding the liquid carrier to the powder formulation to form the solution having a molar concentration of dissolved RSNO ranging from about 500 μM to about 50 mM.

5 . The method as defined in claim 1 wherein the liquid carrier is deionized water.

6 . The method as defined in claim 1 wherein the powder formulation consists of the RSNO powder, an optional additive to control or accelerate a rate of release of NO from the RSNO powder after the powder formulation is dissolved in the liquid carrier, and an optional buffer salt.

7 . The method as defined in claim 1 , further comprising storing the powder formulation in conditions that shield the powder formulation from light and moisture.

8 . The method as defined in claim 1 , wherein the inflatable and nitric oxide permeable balloon is free of a nitric oxide generating agent.

9 . The method as defined in claim 1 , wherein the predetermined time is up to 30 minutes.

Assignees

• Univ Michigan Regents

Inventors

• Meyerhoff Mark E
• Lautner-Csorba Orsolya I
• Murray griffin
• Lautner Gergely
• Yevzlin Alexander S
• Ramani Karthik

Classifications

• A61M2202/0275

  Nitric oxide [NO] · CPC title

• A61M2025/105

  having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes · CPC title

• A61M25/0017

  specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections · CPC title

• A61L29/041

  obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

• A61L29/06

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title